Expert Opinion on Pharmacotherapy 20:133141 Ismail R, Sovny T, Gcsi A, Ambrus R, Katona G, Imre N, Cska I (2019) Synthesis and statistical optimization of poly (lactic-co-glycolic acid) nanoparticles encapsulating glp1 analog designed for oral delivery
The potential of albiglutide, a long-acting GLP-1 receptor agonist, in type 2 diabetes: a randomized controlled trial exploring weekly, biweekly, and monthly dosing [abstract]
Initial reports suggest that six adverse events could be linked to the affected lot, although there is presently no confirmed connection to the counterfeit drugs
This outcome reflects a medically responsible platform appropriately excluding candidates who aren't suitable for GLP-1 treatment
This receptor functions as a tyrosine kinase that initiates intracellular growth cascades once activated
Leah Joseph, MD, FACP , provides expert guidance to help you choose the best treatment for your needs